Technology and innovation watch
ShareAbbott (NYSE: ABT) and Facet Biotech Corporation (Nasdaq: FACT) announced today a definitive agreement for Abbott to acquire Facet, enhancing Abbott’s early- and mid-stage pharmaceutical pipeline. Abbott will acquire Facet for $27 per share in cash for a net transaction value of approximately $450 million, which includes a purchase price of approximately $722 million less [...]
ShareAbbott announced that the U.S. Food and Drug Administration (FDA) has granted approval of a new tablet formulation of the company’s antiretroviral medication Norvir® (ritonavir). The new Norvir tablets can be stored at room temperature and do not require refrigeration, making it more convenient for patients. The Norvir tablets [...]
ShareAbbott Laboratories asked a federal court to block Teva Pharmaceutical Industries Ltd from making a generic version of Abbott’s Simcor cholesterol treatment, according to court documents.
Abbott said its patents were violated when Israel-based Teva filed an application with the U.S. Food and Drug Administration seeking approval to market a generic version of Simcor, according to [...]